↓ Skip to main content

Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study

Overview of attention for article published in Psychopharmacology, May 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users
facebook
3 Facebook pages
reddit
1 Redditor

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
104 Mendeley
citeulike
1 CiteULike
Title
Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study
Published in
Psychopharmacology, May 2011
DOI 10.1007/s00213-011-2347-8
Pubmed ID
Authors

Jon E. Grant, Brian L. Odlaug, Samuel R. Chamberlain, Suck Won Kim

Abstract

Trichotillomania is characterized by repetitive pulling causing noticeable hair loss. Pharmacological treatment data for trichotillomania are limited.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 <1%
Unknown 103 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 19%
Student > Ph. D. Student 11 11%
Student > Master 8 8%
Student > Bachelor 8 8%
Student > Postgraduate 7 7%
Other 19 18%
Unknown 31 30%
Readers by discipline Count As %
Psychology 17 16%
Medicine and Dentistry 16 15%
Pharmacology, Toxicology and Pharmaceutical Science 7 7%
Agricultural and Biological Sciences 7 7%
Neuroscience 7 7%
Other 11 11%
Unknown 39 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2021.
All research outputs
#2,308,678
of 22,665,794 outputs
Outputs from Psychopharmacology
#570
of 5,329 outputs
Outputs of similar age
#11,081
of 111,812 outputs
Outputs of similar age from Psychopharmacology
#5
of 32 outputs
Altmetric has tracked 22,665,794 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,329 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 111,812 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.